These Six2-TGCtg mice express an EGFPCre fusion protein directed to nephron progenitor population cap mesenchyme from the onset of metanephric kidney development by the Six2 (sine oculis-related homeobox 2 homolog (Drosophila)) promoter/enhancer regions within the BAC transgene. Sequence updates published after this transgene was created revealed an upstream Six2 ATG start site that is in-frame with the tTA; thus an apparent and unintended fusion was created with the tTA (80 amino acids potentially added) that renders transgene expression unaffected by tetracycline/doxycycline administration. While not useful as a Tet-Off tool, these Six2-TGCtg mice may be useful as fluorescent or Cre-lox tools for lineage-tracing/marking Six2-expressing cells for studying multipotent nephron progenitor cell populations throughout kidney organogenesis.
Andrew P McMahon, University of Southern California
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Recombinase-expressing, Inducible) |
Sequence updates published after this transgene was created revealed an upstream Six2 ATG start site that is in-frame with the tTA; thus an apparent and unintended fusion was created with the tTA (80 amino acids potentially added) that renders transgene expression unaffected by tetracycline/doxycycline administration.
Hemizygous Six2-TGCtg mice are viable and fertile, harboring a BAC transgene with a Tet-off-eGFPCre under control of the Six2 promoter/enhancer regions within the BAC transgene. The Tet-off-eGFPCre contains both the tetracycline-controlled transactivator protein (tTA) as well as the tetracycline operator (tetO; also called tetracycline-responsive element [TRE] or tet-operator) upstream of an EGFPCre fusion protein. Sequence updates published after this transgene was created revealed an upstream Six2 ATG start site that is in-frame with the tTA; thus an apparent and unintended fusion was created with the tTA (80 amino acids potentially added) that renders transgene expression unaffected by tetracycline/doxycycline administration. It is not known whether the "mutant" tTA is resistant to tetracycline/doxycycline inactivation and still binds to TRE to activate EGFPCre expression or if the TRE acts as a minimal promoter adjacent to the Six2 promoter in the presence of a nonfunctional tTA. Either way, Tet-independent expression of the eGFPCre fusion protein (EGFP immunofluorescence and direct fluorescence/Cre recombinase activity) is directed to nephron progenitor population cap mesenchyme from the onset of metanephric kidney development. When bred with mice containing a loxP-flanked sequence of interest, Cre-mediated recombination will result in deletion of the floxed sequence(s) in such tissues of the offspring. While not useful as a Tet-Off tool, these Six2-TGCtg mice may be useful as fluorescent or Cre-lox tools for lineage-tracing/marking Six2-expressing cells for studying multipotent nephron progenitor cell populations throughout kidney organogenesis. The donating investigator reports they were unable to produce homozygous mice from hemizygous matings.
The ~181 kb C57BL/6J mouse bacterial artificial chromosome (BAC) RPCI23-311C1, containing the entire Six2 locus (and other genes), was modified by targeting a Tet-off-eGFPCre into the ATG start site of the Six2 locus. This inserted a Tet-off cassette (tetracycline-regulated transactivator [tTA], 2xpolyA signal, tetracycline-responsive element [TRE or teto with CMVmin promoter]) followed by an Enhanced Green Fluorescent Protein/Cre Recombinase (EGFP/Cre) fusion protein coding sequence, SV40 polyA signal, and frt-flanked kanamycin cassette. Sequence updates published after this transgene was created revealed an upstream Six2 ATG start site that is in-frame with the tTA; thus an apparent and unintended fusion was created with the tTA (80 amino acids potentially added) that renders transgene expression unaffected by tetracycline/doxycycline administration. The targeted BAC sequences were further modified using FLP recombination to remove the selection cassette and linearized to remove its original vector backbone. The resulting modified BAC was microinjected into CD-1 zygotes. Transgenic founders were obtained and bred to C57BL/6 mice to establish the Six2-TGCtg colony. These mice were subsequently maintained on CD-1;Swiss Webster;C57BL/6 mixed genetic background prior to arrival at The Jackson Laboratory. Upon arrival, transgenic mice were bred with C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish this colony.
Expressed Gene | GFP, Green Fluorescent Protein, |
---|---|
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
Site of Expression | EGFP immunofluorescence is observed in nephron progenitor population cap mesenchyme from the onset of metanephric kidney development. |
Allele Name | transgene insertion 1, Andrew P McMahon |
---|---|
Allele Type | Transgenic (Recombinase-expressing, Inducible) |
Allele Synonym(s) | Six2-TGC(tg); Six2-TGCtg; Tet-off-eGFPCre BAC transgenic; Tg(Six2-tTA,tetO-EGFP/cre)1Amc; TGC BAC transgenic allele |
Gene Symbol and Name | Tg(Six2-EGFP/cre)1Amc, transgene insertion 1, Andrew P McMahon |
Gene Synonym(s) | |
Promoter | Six2, sine oculis-related homeobox 2, mouse, laboratory |
Expressed Gene | GFP, Green Fluorescent Protein, |
Expressed Gene | cre, cre recombinase, bacteriophage P1 |
Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli |
Site of Expression | EGFP immunofluorescence is observed in nephron progenitor population cap mesenchyme from the onset of metanephric kidney development. |
Strain of Origin | CD-1 |
Chromosome | UN |
Molecular Note | The 181 kb C57BL/6J mouse bacterial artificial chromosome (BAC) RPCI23-311C1, containing the entire Six2 locus (and other genes), was modified by targeting a Tet-off-eGFPCre into the ATG start site of the Six2 locus. This inserted a Tet-off cassette (tetracycline-regulated transactivator (tTA), 2xpolyA signal, tetracycline-responsive element (TRE or tetO with CMV min promoter) followed by an Enhanced Greed Fluorescent Protein/Cre Recombinase (EGFP/Cre) fusion protein coding sequence, (SV40 polyA signal), and frt-flanked kanamycin cassette. The targeted BAC sequences were further modified using FLP recombination to remove the selection cassette and linearized to remove its original vector backbone. The resulting modified BAC was microinjected into CD-1 zygotes. Sequence updates published after this transgene was created revealed an upstream Six2 ATG start site that is in-frame with the tTA; thus an apparent and unintended fusion was created with the tTA (80 amino acids potentially added) that renders transgene expression unaffected by tetracycline/doxycycline administration. |
Mutations Made By | Andrew McMahon, University of Southern California |
When maintaining a live colony, hemizygous mice may be bred together or to wildtype (noncarrier) siblings. The donating investigator reports they were unable to produce homozygous mice from hemizygous matings.
When using the STOCK Tg(Six2-EGFP/cre)1Amc/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #009606 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or Non carrier for Tg(Six2-EGFP/cre)1Amc |
Frozen Mouse Embryo | STOCK Tg(Six2-EGFP/cre)1Amc/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(Six2-EGFP/cre)1Amc/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Tg(Six2-EGFP/cre)1Amc/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Tg(Six2-EGFP/cre)1Amc/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.